05.11.26 -- STREAM Edition: Power Your Pipeline — Stream GMP, CDMO & Clinical Supply Insights

Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.

Explore how CDMOs can leverage strategic agility, scale flexibility, and overcome challenges to drive success in a rapidly evolving pharmaceutical landscape.

Leveraging decades of expertise, analytical capabilities, and regulatory knowledge, we deliver phase-appropriate solutions that streamline development, reduce risk, and accelerate timelines.

Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

This segment of the Outsourced Pharma Live event, "Clinical Supply Therapy: Lowering Risk and Your Blood Pressure," addresses the true meaning of resilience in the clinical supply chain. 

An executive view on how biosimilar misconceptions around demand, risk, and cost drove market crowding, manufacturing pressure, and eventual consolidation across the industry.